— Know what they know.
Not Investment Advice

BIEI OTC

Premier Biomedical, Inc.
1W: +10.0% 1M: -8.3% 3M: -15.4% YTD: +10.0% 1Y: -31.2% 3Y: -31.2% 5Y: -83.8%
$0.00
-0.00 (-8.33%)
 
Weekly Expected Move ±26.3%
$0 $0 $0 $0 $0
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 56 · $714989 mcap · 1.27B float · 1.41% daily turnover · Short 43% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.7M
52W Range0.0003-0.002
Volume7,250,673
Avg Volume17,915,694
Beta0.80
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOIvan Mendez
Employees4
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2012-08-15
PO Box 25
Jackson Center, PA 16133
US
About Premier Biomedical, Inc.

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer’s disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.

Recent Insider Trades

NameTypeSharesPriceDate
FELDER MITCHELL S P-Purchase 2,000,000 $0.00 2020-03-27
FELDER MITCHELL S P-Purchase 3,000,000 $0.00 2020-03-26
Borza John Stanley P-Purchase 5,000,000 $0.00 2020-02-04
FELDER MITCHELL S P-Purchase 10,000,000 $0.00 2020-02-03
FELDER MITCHELL S P-Purchase 220,400 $0.01 2019-09-16

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms